“High-sensitivity CRP has been shown to be an independent marker of risk in addition to and in some cases over and above all ...
Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...
Predictive Oncology Inc. has updated shareholders on its advancements in AI-driven drug discovery, specifically in biomarker discovery and drug repurposing, amid a growing biomarker discovery market ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
News-Medical.Net on MSN
Blood lipid–hormone ratios predict future asthma attacks years in advance
By Hugo Francisco de Souza Study: The ratio of circulatory levels of sphingolipids to steroids predicts asthma exacerbations ...
According to MarketsandMarkets™, the Predictive Clinical Biomarkers Market is projected to grow from about USD 8.49 billion ...
Initial plans target European clinical trials while providing standard testing to clinicians for individual patients There are an estimated 250,000 gynecologic cancers diagnosed annually across Europe ...
The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results